Literature DB >> 36083310

[Salvage prostate bed radiotherapy: co-irradiation of regional LNs and significance of ADT].

Felix Grabenbauer1, Michael Flentje2.   

Abstract

Entities:  

Year:  2022        PMID： 36083310     DOI： 10.1007/s00066-022-02001-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   4.033


× No keyword cloud information.
  7 in total

1.  Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

Authors:  Thomas M Pisansky; Shree Agrawal; Daniel A Hamstra; Bridget F Koontz; Stanley L Liauw; Jason A Efstathiou; Jeff M Michalski; Felix Y Feng; Matthew C Abramowitz; Alan Pollack; Mitchell S Anscher; Drew Moghanaki; Robert B Den; Kevin L Stephans; Anthony L Zietman; W Robert Lee; Michael W Kattan; Andrew J Stephenson; Rahul D Tendulkar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-03       Impact factor: 7.038

2.  Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Authors:  Mack Roach; Jennifer Moughan; Colleen A F Lawton; Adam P Dicker; Kenneth L Zeitzer; Elizabeth M Gore; Young Kwok; Michael J Seider; I-Chow Hsu; Alan C Hartford; Eric M Horwitz; Kosj Yamoah; Christopher U Jones; Jeff M Michalski; W Robert Lee; Thomas M Pisansky; Rachel Rabinovitch; Marvin Rotman; Rodger M Pryzant; Harold E Kim; Charles R Thomas; William U Shipley; Howard M Sandler
Journal:  Lancet Oncol       Date:  2018-10-10       Impact factor: 41.316

3.  Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.

Authors:  Louise Emmett; Pim J van Leeuwen; Rohan Nandurkar; Matthijs J Scheltema; Thomas Cusick; George Hruby; Andrew Kneebone; Thomas Eade; Gerald Fogarty; Raj Jagavkar; Quoc Nguyen; Bao Ho; Anthony M Joshua; Phillip Stricker
Journal:  J Nucl Med       Date:  2017-07-26       Impact factor: 10.057

4.  Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial.

Authors:  Xin Qi; Hong-Zhen Li; Xian-Shu Gao; Shang-Bin Qin; Min Zhang; Xiao-Mei Li; Xiao-Ying Li; Ming-Wei Ma; Yun Bai; Xue-Ying Li; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-10-25       Impact factor: 7.038

5.  Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Authors:  Pirus Ghadjar; Stefanie Hayoz; Jürg Bernhard; Daniel R Zwahlen; Tobias Hölscher; Philipp Gut; Bülent Polat; Guido Hildebrandt; Arndt-Christian Müller; Ludwig Plasswilm; Alexandros Papachristofilou; Corinne Schär; Marcin Sumila; Kathrin Zaugg; Matthias Guckenberger; Piet Ost; Christiane Reuter; Davide G Bosetti; Kaouthar Khanfir; Silvia Gomez; Peter Wust; George N Thalmann; Daniel M Aebersold
Journal:  Eur Urol       Date:  2021-06-14       Impact factor: 20.096

6.  Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.

Authors:  Claire L Vale; David Fisher; Andrew Kneebone; Christopher Parker; Maria Pearse; Pierre Richaud; Paul Sargos; Matthew R Sydes; Christopher Brawley; Meryem Brihoum; Chris Brown; Sylvie Chabaud; Adrian Cook; Silvia Forcat; Carol Fraser-Browne; Igor Latorzeff; Mahesh K B Parmar; Jayne F Tierney
Journal:  Lancet       Date:  2020-09-28       Impact factor: 79.321

7.  Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy.

Authors:  Dirk Bottke; Jonathan Miksch; Reinhard Thamm; Thomas Krohn; Detlef Bartkowiak; Meinrad Beer; Christian Bolenz; Ambros J Beer; Vikas Prasad; Thomas Wiegel
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.